NO995842L - Multicykliske erytromycinderivater - Google Patents
Multicykliske erytromycinderivaterInfo
- Publication number
- NO995842L NO995842L NO995842A NO995842A NO995842L NO 995842 L NO995842 L NO 995842L NO 995842 A NO995842 A NO 995842A NO 995842 A NO995842 A NO 995842A NO 995842 L NO995842 L NO 995842L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- pharmaceutically acceptable
- effective amount
- therapeutically effective
- erythromycin derivatives
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Nye multicykliske erytromycinforbindelser og farmasøytisk akseptable salter og estere derav som har antibakteriell aktivitet, hvilke har formlene (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX), (X) eller (XI), farmasøytiske sammensetninger omfattende en terapeutisk effektiv mengde av en forbindelse av oppfinnelsen i kombinasjon med en far- masøytisk akseptabel bærer, samt en fremgangsmåte for å behandle bakterielle infeksjoner ved å administrere til et pattedyr en farmasøytisk sammensetning inneholdende en terapeutisk effektiv mengde av en forbindelse med formel(I)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86545397A | 1997-05-29 | 1997-05-29 | |
| PCT/US1998/010501 WO1998054197A1 (en) | 1997-05-29 | 1998-05-22 | Multicyclic erythromycin derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO995842D0 NO995842D0 (no) | 1999-11-29 |
| NO995842L true NO995842L (no) | 2000-01-26 |
Family
ID=25345545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO995842A NO995842L (no) | 1997-05-29 | 1999-11-29 | Multicykliske erytromycinderivater |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0984975B1 (no) |
| JP (1) | JP4368950B2 (no) |
| KR (1) | KR20010013041A (no) |
| CN (1) | CN1258299A (no) |
| AR (1) | AR013081A1 (no) |
| AT (1) | ATE238330T1 (no) |
| AU (1) | AU7591298A (no) |
| BG (1) | BG103985A (no) |
| BR (1) | BR9809489A (no) |
| CA (1) | CA2290421C (no) |
| CO (1) | CO4950620A1 (no) |
| DE (1) | DE69813798T2 (no) |
| DK (1) | DK0984975T3 (no) |
| ES (1) | ES2197472T3 (no) |
| HU (1) | HUP0004809A3 (no) |
| IL (1) | IL132482A0 (no) |
| MX (1) | MXPA99011001A (no) |
| NO (1) | NO995842L (no) |
| NZ (1) | NZ500531A (no) |
| PL (1) | PL337066A1 (no) |
| PT (1) | PT984975E (no) |
| SI (1) | SI0984975T1 (no) |
| SK (1) | SK160299A3 (no) |
| TR (1) | TR199902820T2 (no) |
| WO (1) | WO1998054197A1 (no) |
| ZA (1) | ZA984488B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE250076T1 (de) * | 1999-06-07 | 2003-10-15 | Abbott Lab | 6-o-carbamat ketolide derivate |
| EP1841775A2 (en) * | 2005-01-12 | 2007-10-10 | Alpharma APS | Erythromycin derivatives as antibacterial agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5631355A (en) * | 1992-04-22 | 1997-05-20 | Taisho Pharmaceutical Co., Ltd. | 5-O-desosaminylerythronolide a derivatives |
| ES2218604T3 (es) * | 1995-11-08 | 2004-11-16 | Abbott Laboratories | Derivados triciclicos de eritromicina. |
-
1998
- 1998-05-22 CA CA002290421A patent/CA2290421C/en not_active Expired - Fee Related
- 1998-05-22 DK DK98923678T patent/DK0984975T3/da active
- 1998-05-22 DE DE69813798T patent/DE69813798T2/de not_active Expired - Fee Related
- 1998-05-22 EP EP98923678A patent/EP0984975B1/en not_active Expired - Lifetime
- 1998-05-22 MX MXPA99011001A patent/MXPA99011001A/es not_active IP Right Cessation
- 1998-05-22 SK SK1602-99A patent/SK160299A3/sk unknown
- 1998-05-22 HU HU0004809A patent/HUP0004809A3/hu unknown
- 1998-05-22 AU AU75912/98A patent/AU7591298A/en not_active Abandoned
- 1998-05-22 TR TR1999/02820T patent/TR199902820T2/xx unknown
- 1998-05-22 CN CN98805510A patent/CN1258299A/zh active Pending
- 1998-05-22 SI SI9830449T patent/SI0984975T1/xx unknown
- 1998-05-22 PT PT98923678T patent/PT984975E/pt unknown
- 1998-05-22 PL PL98337066A patent/PL337066A1/xx unknown
- 1998-05-22 ES ES98923678T patent/ES2197472T3/es not_active Expired - Lifetime
- 1998-05-22 JP JP50078099A patent/JP4368950B2/ja not_active Expired - Fee Related
- 1998-05-22 IL IL13248298A patent/IL132482A0/xx unknown
- 1998-05-22 BR BR9809489-0A patent/BR9809489A/pt not_active IP Right Cessation
- 1998-05-22 KR KR1019997011017A patent/KR20010013041A/ko not_active Withdrawn
- 1998-05-22 NZ NZ500531A patent/NZ500531A/en unknown
- 1998-05-22 WO PCT/US1998/010501 patent/WO1998054197A1/en not_active Ceased
- 1998-05-22 AT AT98923678T patent/ATE238330T1/de not_active IP Right Cessation
- 1998-05-26 ZA ZA984488A patent/ZA984488B/xx unknown
- 1998-05-27 CO CO98029719A patent/CO4950620A1/es unknown
- 1998-05-28 AR ARP980102489A patent/AR013081A1/es unknown
-
1999
- 1999-11-29 NO NO995842A patent/NO995842L/no not_active Application Discontinuation
- 1999-12-10 BG BG103985A patent/BG103985A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2290421A1 (en) | 1998-12-03 |
| DE69813798T2 (de) | 2004-02-19 |
| MXPA99011001A (es) | 2003-09-10 |
| TR199902820T2 (xx) | 2000-04-21 |
| HUP0004809A3 (en) | 2001-11-28 |
| ES2197472T3 (es) | 2004-01-01 |
| ATE238330T1 (de) | 2003-05-15 |
| DE69813798D1 (en) | 2003-05-28 |
| HUP0004809A2 (hu) | 2001-05-28 |
| PL337066A1 (en) | 2000-07-31 |
| DK0984975T3 (da) | 2003-08-11 |
| EP0984975A1 (en) | 2000-03-15 |
| IL132482A0 (en) | 2001-03-19 |
| JP4368950B2 (ja) | 2009-11-18 |
| BG103985A (en) | 2000-07-31 |
| EP0984975B1 (en) | 2003-04-23 |
| NO995842D0 (no) | 1999-11-29 |
| ZA984488B (en) | 1998-12-02 |
| BR9809489A (pt) | 2000-06-20 |
| KR20010013041A (ko) | 2001-02-26 |
| JP2002500669A (ja) | 2002-01-08 |
| NZ500531A (en) | 2001-07-27 |
| AR013081A1 (es) | 2000-12-13 |
| PT984975E (pt) | 2003-09-30 |
| SI0984975T1 (en) | 2004-02-29 |
| WO1998054197A1 (en) | 1998-12-03 |
| CN1258299A (zh) | 2000-06-28 |
| SK160299A3 (en) | 2000-06-12 |
| CO4950620A1 (es) | 2000-09-01 |
| CA2290421C (en) | 2007-05-08 |
| AU7591298A (en) | 1998-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20001169L (no) | 6,9-bro erythromycinderivater | |
| NO20002099L (no) | 6,11-bro-erytromycinderivater | |
| DK0766672T3 (da) | Arylsulfonamido-substituerede hydroxamsyrer som matrixmetallopreteinase-inhibitorer | |
| AP9701039A0 (en) | Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one. | |
| DE69904302D1 (de) | Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung | |
| TR199901127T2 (xx) | Antibakteriyel etkili 6-O-ikameli ketolitler. | |
| NO20001439L (no) | 3'-N-modifiserte 6-O-substituerte erytromycin ketolid- derivater med antibakteriell aktivitet | |
| NO20061657L (no) | Pyrolderivater med antibakteriell aktivitet | |
| PT928788E (pt) | Compostos farmaceuticamente activos | |
| NO996108L (no) | 9-oksinerytromycinderivater | |
| CA2307788A1 (en) | 2-halo-6-o-substituted ketolide derivatives | |
| AU7263591A (en) | Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors | |
| CA2327775A1 (en) | 15-membered lactams ketolides with antibacterial activity | |
| ATE259823T1 (de) | Tricyclische erythromycinderivate | |
| BR9708068A (pt) | Método de inibição da replicação de citomegalovìrus em um mamìfero, composição anti- citomegalovìrus e composto. | |
| BR9708929A (pt) | Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos | |
| NO20053483L (no) | 4-Anilinokinazolinderivater for behandling av unormal cellevekst | |
| WO1999011651A3 (en) | 3-descladinose 6-o-substituded erythromycin derivatives | |
| NO20045132L (no) | Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer | |
| CA2382654A1 (en) | Novel a-500359 derivatives | |
| CA2290421A1 (en) | Multicyclic erythromycin derivatives | |
| NO942181L (no) | ||
| MXPA05008190A (es) | Derivado de oligosacarido. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |